Article Details

Sanofi and C4X Discovery enter licensing deal worth up to €414m

Retrieved on: 2021-04-12 14:37:30

Tags for this article:

Click the tags to see associated articles and topics

Sanofi and C4X Discovery enter licensing deal worth up to €414m. View article details on hiswai:

Excerpt

Current treatments targeting IL-17 are monoclonal antibodies administered via an injection. There is an urgent need for safe and effective oral small ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up